US Bancorp’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-253
| Closed | -$6.1K | – | 4146 |
|
2023
Q1 | $6.1K | Buy |
253
+86
| +51% | +$2.07K | ﹤0.01% | 3441 |
|
2022
Q4 | $1.77K | Buy |
+167
| New | +$1.77K | ﹤0.01% | 3787 |
|
2022
Q3 | – | Sell |
-3,000
| Closed | -$12K | – | 4245 |
|
2022
Q2 | $12K | Sell |
3,000
-521
| -15% | -$2.08K | ﹤0.01% | 3307 |
|
2022
Q1 | $26K | Hold |
3,521
| – | – | ﹤0.01% | 2931 |
|
2021
Q4 | $20K | Sell |
3,521
-2,931
| -45% | -$16.6K | ﹤0.01% | 3108 |
|
2021
Q3 | $41K | Buy |
6,452
+213
| +3% | +$1.35K | ﹤0.01% | 2732 |
|
2021
Q2 | $53K | Buy |
6,239
+1,239
| +25% | +$10.5K | ﹤0.01% | 2638 |
|
2021
Q1 | $52K | Buy |
5,000
+2,000
| +67% | +$20.8K | ﹤0.01% | 2562 |
|
2020
Q4 | $51K | Hold |
3,000
| – | – | ﹤0.01% | 2498 |
|
2020
Q3 | $38K | Hold |
3,000
| – | – | ﹤0.01% | 2507 |
|
2020
Q2 | $42K | Hold |
3,000
| – | – | ﹤0.01% | 2460 |
|
2020
Q1 | $28K | Hold |
3,000
| – | – | ﹤0.01% | 2559 |
|
2019
Q4 | $45K | Hold |
3,000
| – | – | ﹤0.01% | 2513 |
|
2019
Q3 | $20K | Hold |
3,000
| – | – | ﹤0.01% | 2851 |
|
2019
Q2 | $36K | Buy |
+3,000
| New | +$36K | ﹤0.01% | 2679 |
|